Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 4/2022

Open Access 01-04-2022 | Esophagography | Invited Review

Pathophysiology of Dysphagia in Eosinophilic Esophagitis: Causes, Consequences, and Management

Authors: Edward Young, Hamish Philpott

Published in: Digestive Diseases and Sciences | Issue 4/2022

Login to get access

Abstract

Eosinophilic esophagitis (EoE) is a leading cause of food bolus impaction in children and adults. The mechanism of dysphagia in EoE, particularly non-obstructive dysphagia, remains incompletely understood. While fibrostenotic processes appear to be critical in the development of dysphagia, somatosensory dysfunction and dysmotility also contribute. This review considers potential mechanisms of dysphagia and evaluates the utility of current and future treatment strategies in this context.
Literature
1.
Lucendo AJ, Molina-Infante J, Arias Á et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United Eur Gastroenterol J 2017;5:335–358.
2.
Dellon ES, Hirano I. Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology 2018;154:319-332.e313.PubMed
3.
Eke R, Dellon ES. Hospitalization trends and determinants of inpatient costs for eosinophilic esophagitis patients in the United States: results from the Nationwide Inpatient Sample analysis. Ann Gastroenterol 2021; 1–9.
4.
Heerasing N, Lee SY, Alexander S, Dowling D. Prevalence of eosinophilic esophagitis in adults presenting with esophageal food bolus obstruction. World J Gastrointest Pharmacol Ther 2015;6:244–247.PubMedPubMedCentral
5.
Cook D, Zala A, Bollipo S, Potter MDE, Walker MM, Talley NJ. Esophageal food bolus obstruction and eosinophilic esophagitis. Internal Med J 2019;49:1032–1034.
6.
Lucendo AJ, Arias-González L, Molina-Infante J, Arias Á. Determinant factors of quality of life in adult patients with eosinophilic esophagitis. United Eur Gastroenterol J 2018;6:38–45.
7.
Aiolfi A, Ferrari D, Riva CG, Toti F, Bonitta G, Bonavina L. Esophageal foreign bodies in adults: systematic review of the literature. Scand J Gastroenterol 2018;53:1171–1178.PubMed
8.
Taft TH, Guadagnoli L, Edlynn E. Anxiety and depression in eosinophilic esophagitis: a scoping review and recommendations for future research. J Asthma Allergy 2019;12:389–399.PubMedPubMedCentral
9.
Larsson H, Norder Grusell E, Tegtmeyer B, Ruth M, Bergquist H, Bove M. Grade of eosinophilia versus symptoms in patients with dysphagia and esophageal eosinophilia. Dis Esophagus 2016;29:971–976.PubMed
10.
Pentiuk S, Putnam PE, Collins MH, Rothenberg ME. Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2009;48:152–160.PubMedPubMedCentral
11.
Alexander JA, Jung KW, Arora AS et al. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2012;10:742-749.e741.PubMed
12.
Broide D. Immunologic and inflammatory mechanisms that drive asthma progression to remodelling. J Allergy Clin Immunol 2008;121:560–572.PubMedPubMedCentral
13.
Aceves SS. Remodeling and fibrosis in chronic eosinophil inflammation. Dig Dis 2014;32:15–21.PubMed
14.
Blanchard C, Wang N, Stringer KF et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006;116:536–547.PubMedPubMedCentral
15.
Furuta GT, Liacouras CA, Collins MH et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007;133:1342–1363.PubMed
16.
Whelan KA, Godwin BC, Wilkins B et al. Persistent basal cell hyperplasia is associated with clinical and endoscopic findings in patients with histologically inactive eosinophilic esophagitis. Clin Gastroenterol Hepatol 2020;18:1475-1482.e1471.PubMed
17.
Mishra A, Wang M, Pemmaraju VR et al. Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology 2008;134:204–214.PubMed
18.
Williamson P, Proudfoot J, Gharibans A et al. Plasminogen activator inhibitor-1 as a marker of esophageal functional changes in pediatric eosinophilic esophagitis. Clin Gastroenterol Hepatol 2020.
19.
Al-Hussaini A, AboZeid A, Hai A. How does esophagus look on barium esophagram in pediatric eosinophilic esophagitis? Abdom Radiol 2016;41:1466–1473.
20.
Aceves SS, Ackerman SJ. Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis. Immunol Allergy Clin N Am 2009;29:197–xiv.
21.
Fox VL, Nurko S, Teitelbaum JE, Badizadegan K, Furuta GT. High-resolution EUS in children with eosinophilic “allergic” esophagitis. Gastrointest Endosc 2003;57:30–36.PubMed
22.
Mann NS, Leung JW. Pathogenesis of esophageal rings in eosinophilic esophagitis. Med Hypotheses 2005;64:520–523.PubMed
23.
Niranjan R, Mavi P, Rayapudi M, Dynda S, Mishra A. Pathogenic role of mast cells in experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol 2013;304:G1087-1094.PubMedPubMedCentral
24.
25.
Rodríguez-Sánchez J, Barrio-Andrés J, Nantes Castillejo O et al. The endoscopic reference score shows modest accuracy to predict either clinical or histological activity in adult patients with eosinophilic esophagitis. Aliment Pharmacol Ther 2017;45:300–309.PubMed
26.
Persad R, Huynh HQ, Hao L et al. Angiogenic remodeling in pediatric EoE is associated with increased levels of VEGF-A, angiogenin, IL-8, and activation of the TNF-α-NFκB pathway. J Pediatr Gastroenterol Nutr 2012;55:251–260.PubMed
27.
Aceves SS, Newbury RO, Dohil R, Bastian JF, Broide DH. Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol 2007;119:206–212.PubMed
28.
McNamee EN, Biette KA, Hammer J et al. Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis. Allergy 2017;72:1232–1242.PubMed
29.
Dellon ES, Kim HP, Sperry SL, Rybnicek DA, Woosley JT, Shaheen NJ. A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointest Endosc 2014;79:577-585.e574.PubMed
30.
Schoepfer AM, Safroneeva E, Bussmann C et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology 2013;145:1230–1236.e1231–1232.
31.
Singla MB, Chehade M, Brizuela D et al. Early comparison of inflammatory vs. fibrostenotic phenotype in eosinophilic esophagitis in a multicenter longitudinal study. Clin Transl Gastroenterol 2015;6:e132–e132.PubMedPubMedCentral
32.
Koutlas NT, Dellon ES. Progression from an Inflammatory to a fibrostenotic phenotype in eosinophilic esophagitis. Case Rep Gastroenterol 2017;11:382–388.PubMedPubMedCentral
33.
Warners MJ, Oude Nijhuis RAB, de Wijkerslooth LRH, Smout A, Bredenoord AJ. The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort. Am J Gastroenterol 2018;113:836–844.PubMed
34.
Chehade M, Sampson HA, Morotti RA, Magid MS. Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2007;45:319–328.PubMed
35.
Li-Kim-Moy JP, Tobias V, Day AS, Leach S, Lemberg DA. Esophageal subepithelial fibrosis and hyalinization are features of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2011;52:147–153.PubMed
36.
Lucendo AJ, Arias A, De Rezende LC et al. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study. J Allergy Clin Immunol 2011;128:1037–1046.PubMed
37.
Rieder F, Nonevski I, Ma J et al. T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis. Gastroenterology 2014;146:1266–1277.e1261–1269.
38.
Mavi P, Rajavelu P, Rayapudi M, Paul RJ, Mishra A. Esophageal functional impairments in experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol 2012;302:G1347-1355.PubMedPubMedCentral
39.
Vasilopoulos S, Murphy P, Auerbach A et al. The small-caliber esophagus: an unappreciated cause of dysphagia for solids in patients with eosinophilic esophagitis. Gastrointest Endosc 2002;55:99–106.PubMed
40.
Eluri S, Runge TM, Cotton CC et al. The extremely narrow-caliber esophagus is a treatment-resistant subphenotype of eosinophilic esophagitis. Gastrointest Endosc 2016;83:1142–1148.PubMed
41.
Schoepfer AM, Gonsalves N, Bussmann C et al. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol 2010;105:1062–1070.PubMed
42.
Rodriguez-Sanchez J, Barrio-Andres J, Nantes Castillejo O et al. The endoscopic reference score shows modest accuracy to predict either clinical or histological activity in adult patients with eosinophilic esophagitis. Aliment Pharmacol Ther 2017;45:300–309.PubMed
43.
Menard-Katcher C, Swerdlow MP, Mehta P, Furuta GT, Fenton LZ. Contribution of esophagram to the evaluation of complicated pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2015;61:541–546.PubMedPubMedCentral
44.
Nelson MJ, Miller FH, Moy N et al. Comparison of endoscopy and radiographic imaging for detection of esophageal inflammation and remodeling in adults with eosinophilic esophagitis. Gastrointest Endosc 2018;87:962–968.PubMed
45.
Gentile N, Katzka D, Ravi K et al. Esophageal narrowing is common and frequently under-appreciated at endoscopy in patients with esophageal eosinophilia. Aliment Pharmacol Ther 2014;40:1333–1340.PubMed
46.
Muinuddin A, O’Brien PG, Hurlbut DJ, Paterson WG. Diffuse esophageal narrowing in eosinophilic esophagitis: a barium contrast study. J Can Assoc Gastroenterol 2019;2:1–5.PubMed
47.
Podboy A, Katzka DA, Enders F et al. Esophageal narrowing on barium esophagram is more common in adult patients with eosinophilic esophagitis than PPI-responsive esophageal eosinophilia. Aliment Pharmacol Ther 2016;43:1168–1177.PubMed
48.
Savarino E, Tolone S, Caccaro R et al. Clinical, endoscopic, histological and radiological characteristics of Italian patients with eosinophilic esophagitis. Dig Liver Dis 2015;47:1033–1038.PubMed
49.
Lee J, Huprich J, Kujath C et al. Esophageal diameter is decreased in some patients with eosinophilic esophagitis and might increase with topical corticosteroid therapy. Clin Gastroenterol Hepatol 2012;10:481–486.PubMed
50.
Diniz LO, Putnum PE, Towbin AJ. Fluoroscopic findings in pediatric eosinophilic esophagitis. Pediatr Radiol 2012;42:721–727.PubMed
51.
White SB, Levine MS, Rubesin SE, Spencer GS, Katzka DA, Laufer I. The small-caliber esophagus: radiographic sign of idiopathic eosinophilic esophagitis. Radiology 2010;256:127–134.PubMed
52.
Donnan EN, Pandolfino JE. EndoFLIP in the esophagus: assessing sphincter function, wall stiffness, and motility to guide treatment. Gastroenterol Clin N Am 2020;49:427–435.
53.
Donnan EN, Pandolfino JE. Applying the functional luminal imaging probe to esophageal disorders. Curr Gastroenterol Rep 2020;22:10.PubMed
54.
Carlson DA, Kou W, Lin Z et al. Normal values of esophageal distensibility and distension-induced contractility measured by functional luminal imaging probe panometry. Clin Gastroenterol Hepatol 2019;17:674-681.e671.PubMed
55.
Nicodème F, Hirano I, Chen J et al. Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2013;11:1101-1107.e1101.PubMedPubMedCentral
56.
Horii Y, Dohi O, Naito Y et al. Efficacy of magnifying narrow band imaging for delineating horizontal margins of early gastric cancer. Digestion 2019;100:93–99.PubMed
57.
Chen JW, Pandolfino JE, Lin Z et al. Severity of endoscopically identified esophageal rings correlates with reduced esophageal distensibility in eosinophilic esophagitis. Endoscopy 2016;48:794–801.PubMedPubMedCentral
58.
Hassan M, Aceves S, Dohil R et al. Esophageal compliance quantifies epithelial remodeling in pediatric patients with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2019;68:559–565.PubMedPubMedCentral
59.
Kwiatek MA, Hirano I, Kahrilas PJ, Rothe J, Luger D, Pandolfino JE. Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology 2011;140:82–90.PubMed
60.
Menard-Katcher C, Benitez AJ, Pan Z et al. Influence of age and eosinophilic esophagitis on esophageal distensibility in a pediatric cohort. Am J Gastroenterol 2017;112:1466–1473.PubMedPubMedCentral
61.
Carlson DA, Hirano I, Zalewski A, Gonsalves N, Lin Z, Pandolfino JE. Improvement in esophageal distensibility in response to medical and diet therapy in eosinophilic esophagitis. Clin Transl Gastroenterol 2017;8:e119.PubMedPubMedCentral
62.
Hirano I, Pandolfino JE, Boeckxstaens GE. Functional lumen imaging probe for the management of esophageal disorders: expert review from the clinical practice updates committee of the AGA institute. Clin Gastroenterol Hepatol 2017;15:325–334.PubMedPubMedCentral
63.
Aceves SS, Chen D, Newbury RO, Dohil R, Bastian JF, Broide DH. Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction. J Allergy Clin Immunol 2010;126:1198-1204.e1194.PubMed
64.
Philpott H, Nandurkar S, Royce SG, Gibson PR. Ultrathin unsedated transnasal gastroscopy in monitoring eosinophilic esophagitis. J Gastroenterol Hepatol 2016;31:590–594.PubMed
65.
Collins MH, Martin LJ, Alexander ES et al. Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring. Dis Esophagus 2017;30:1–8.PubMed
66.
Saffari H, Peterson KA, Fang JC, Teman C, Gleich GJ, Pease LF 3rd. Patchy eosinophil distributions in an esophagectomy specimen from a patient with eosinophilic esophagitis: implications for endoscopic biopsy. J Allergy Clin Immunol 2012;130:798–800.PubMedPubMedCentral
67.
Fontillón M, Lucendo AJ. Transmural eosinophilic infiltration and fibrosis in a patient with non-traumatic Boerhaave’s syndrome due to eosinophilic esophagitis. Am J Gastroenterol 2012;107:1762.PubMed
68.
Nicholson AG, Li D, Pastorino U, Goldstraw P, Jeffery PK. Full thickness eosinophilia in esophageal leiomyomatosis and idiopathic eosinophilic esophagitis. A common allergic inflammatory profile? J Pathol 1997;183:233–236.PubMed
69.
Korsapati H, Babaei A, Bhargava V, Dohil R, Quin A, Mittal RK. Dysfunction of the longitudinal muscles of the esophagus in eosinophilic esophagitis. Gut 2009;58:1056–1062.PubMed
70.
Mankad R, Bonnichsen C, Mankad S. Hypereosinophilic syndrome: cardiac diagnosis and management. Heart 2016;102:100–106.PubMed
71.
Rosenberg HF, Dyer KD, Foster PS. Eosinophils: changing perspectives in health and disease. Nat Rev Immunol 2013;13:9–22.PubMed
72.
Daniel EE, Crankshaw J, Sarna S. Prostaglandins and myogenic control of tension in lower esophageal sphincter in vitro. Prostaglandins 1979;17:629–639.PubMed
73.
Spechler SJ. Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations. J Gastroenterol 2019;54:837–844.PubMedPubMedCentral
74.
Gleich GJ, Adolphson CR, Leiferman KM. The biology of the eosinophilic leukocyte. Annu Rev Med 1993;44:85–101.PubMed
75.
King D, Thomas T, Chandan JS et al. Achalasia is associated with atopy in patients younger than 40 years of age. Am J Gastroenterol 2021;116:416–419.PubMed
76.
Cools-Lartigue J, Chang SY, McKendy K et al. Pattern of esophageal eosinophilic infiltration in patients with achalasia and response to Heller myotomy and Dor fundoplication. Dis Esophagus 2013;26:766–775.PubMed
77.
Savarino E, Gemignani L, Zentilin P et al. Achalasia with dense eosinophilic infiltrate responds to steroid therapy. Clin Gastroenterol Hepatol 2011;9:1104–1106.PubMed
78.
Ghisa M, Laserra G, Marabotto E et al. Achalasia and obstructive motor disorders are not uncommon in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2021;19:1554–1563.PubMed
79.
Park W, Vaezi MF. Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol 2005;100:1404–1414.PubMed
80.
Hejazi RA, Reddymasu SC, Sostarich S, McCallum RW. Disturbances of esophageal motility in eosinophilic esophagitis: a case series. Dysphagia 2010;25:231–237.PubMed
81.
von Arnim U, Kandulski A, Weigt J, Malfertheiner P. Correlation of high-resolution manometric findings with symptoms of dysphagia and endoscopic features in adults with eosinophilic esophagitis. Dig Dis 2017;35:472–477.
82.
Martín Martín L, Santander C, Lopez Martín MC et al. Esophageal motor abnormalities in eosinophilic esophagitis identified by high-resolution manometry. J Gastroenterol Hepatol 2011;26:1447–1450.PubMed
83.
Nurko S, Rosen R, Furuta GT. Esophageal dysmotility in children with eosinophilic esophagitis: a study using prolonged esophageal manometry. Am J Gastroenterol 2009;104:3050–3057.PubMedPubMedCentral
84.
Colizzo JM, Clayton SB, Richter JE. Intrabolus pressure on high-resolution manometry distinguishes fibrostenotic and inflammatory phenotypes of eosinophilic esophagitis. Dis Esophagus 2016;29:551–557.PubMed
85.
Nennstiel S, Bajbouj M, Becker V et al. High-resolution manometry in patients with eosinophilic esophagitis under topical steroid therapy-a prospective observational study (HIMEOS-study). Neurogastroenterol Motil 2016;28:599–607.PubMed
86.
van Rhijn BD, Oors JM, Smout AJ, Bredenoord AJ. Prevalence of esophageal motility abnormalities increases with longer disease duration in adult patients with eosinophilic esophagitis. Neurogastroenterol Motil 2014;26:1349–1355.PubMed
87.
Monnerat MM, Lemme EM. Eosinophilic esophagitis: manometric and pHmetric findings. Arq Gastroenterol 2012;49:113–117.PubMed
88.
89.
Roman S, Hirano I, Kwiatek MA et al. Manometric features of eosinophilic esophagitis in esophageal pressure topography. Neurogastroenterol Motil 2011;23:208–214, e111.
90.
Bassett J, Maydonovitch C, Perry J, Sobin L, Osgard E, Wong R. Prevalence of esophageal dysmotility in a cohort of patients with esophageal biopsies consistent with eosinophilic esophagitis. Dis Esophagus 2009;22:543–548.PubMed
91.
Martín Martín L, Santander Vaquero C, Sánchez Prudencio S, Cantero Perona J, Gisbert JP, Moreno-Otero R. Eosinophilic esophagitis in the adult–clinical, endoscopic, pH-metric, and manometric findings. Rev Esp Enferm Dig 2008;100:476–480.PubMed
92.
Miwa H, Kondo T, Oshima T, Fukui H, Tomita T, Watari J. Esophageal sensation and esophageal hypersensitivity - overview from bench to bedside. J Neurogastroenterol Motil 2010;16:353–362.PubMedPubMedCentral
93.
Bielefeldt K, Davis BM. Differential effects of ASIC3 and TRPV1 deletion on gastresophageal sensation in mice. Am J Physiol Gastrointest Liver Physiol 2008;294:G130-138.PubMed
94.
Guarino MP, Cheng L, Ma J et al. Increased TRPV1 gene expression in esophageal mucosa of patients with non-erosive and erosive reflux disease. Neurogastroenterol Motil 2010;22:746–751, e219.
95.
Tack J, Pandolfino JE. Pathophysiology of gastresophageal reflux disease. Gastroenterology 2018;154:277–288.PubMed
96.
Byrne PJ, Mulligan ED, O’Riordan J, Keeling PW, Reynolds JV. Impaired visceral sensitivity to acid reflux in patients with Barrett’s esophagus. The role of esophageal motility. Dis Esophagus 2003;16:199–203.PubMed
97.
Wong S, Ellison S, Haj Ali S et al. Characteristics and progression of childhood-onset and adult-onset eosinophilic esophagitis. J Gastroenterol Hepatol 2021.
98.
Mahesh VN, Holloway RH, Nguyen NQ. Changing epidemiology of food bolus impaction: is eosinophilic esophagitis to blame? J Gastroenterol Hepatol 2013;28:963–966.PubMed
99.
Sperry SL, Crockett SD, Miller CB, Shaheen NJ, Dellon ES. Esophageal foreign-body impactions: epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis. Gastrointest Endosc 2011;74:985–991.PubMedPubMedCentral
100.
Katzka DA. Demographic data and symptoms of eosinophilic esophagitis in adults. Gastrointest Endosc Clin N Am 2008;18:25–32; viii.
101.
Prasad GA, Talley NJ, Romero Y et al. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol 2007;102:2627–2632.PubMed
102.
Lee KH, Kim JE, Park CJ. Peripheral neuropathy associated withhypereosinophilic syndrome. Ann Dermatol 2008;20:149–152.PubMedPubMedCentral
103.
Chao CC, Hsieh ST, Shun CT, Hsieh SC. Skin denervation and cutaneous vasculitis in eosinophilia-associated neuropathy. Arch Neurol 2007;64:959–965.PubMed
104.
Foster EL, Simpson EL, Fredrikson LJ et al. Eosinophils increase neuron branching in human and murine skin and in vitro. PLoS One 2011;6:e22029.PubMedPubMedCentral
105.
Drake MG, Scott GD, Blum ED et al. Eosinophils increase airway sensory nerve density in mice and in human asthma. Sci Transl Med 2018;10.
106.
Wai K. Eosinophils increase transient receptor potential V1 and substance P expression in Dorsal Root Ganglia in vivo. PSU McNair Scholars Online J 2019;13.
107.
Kapel RC, Miller JK, Torres C, Aksoy S, Lash R, Katzka DA. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology 2008;134:1316–1321.PubMed
108.
Hirano I, Chan ES, Rank MA et al. AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis. Ann Allergy Asthma Immunol 2020;124:416–423.PubMedPubMedCentral
109.
Lucendo AJ, Arias Á, Molina-Infante J. Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2016;14:13-22.e11.PubMed
110.
111.
de Heer J, Miehlke S, Rösch T et al. Histologic and clinical effects of different topical corticosteroids for eosinophilic esophagitis: lessons from an updated meta-analysis of placebo-controlled randomized trials. Digestion 2021;102:377–385.PubMed
112.
Murali AR, Gupta A, Attar BM, Ravi V, Koduru P. Topical steroids in eosinophilic esophagitis: systematic review and meta-analysis of placebo-controlled randomized clinical trials. J Gastroenterol Hepatol 2016;31:1111–1119.PubMed
113.
Dellon ES, Katzka DA, Collins MH et al. Budesonide oral suspension improves symptomatic, endoscopic, and histologic parameters compared with placebo in patients with eosinophilic esophagitis. Gastroenterology 2017;152:776-786.e775.PubMed
114.
Dellon ES, Woosley JT, Arrington A et al. Efficacy of budesonide vs fluticasone for initial treatment of eosinophilic esophagitis in a randomized controlled trial. Gastroenterology 2019;157:65-73.e65.PubMed
115.
Lucendo AJ, Miehlke S, Schlag C et al. Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial. Gastroenterology 2019;157:74-86.e15.PubMed
116.
Arias Á, González-Cervera J, Tenias JM, Lucendo AJ. Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology 2014;146:1639–1648.PubMed
117.
Chehade M, Brown S. Elimination diets for eosinophilic esophagitis: making the best choice. Expert Rev Clin Immunol 2020;16:679–687.PubMed
118.
Straumann A, Conus S, Degen L et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology 2010;139:1526–1537, 1537.e1521.PubMed
119.
Yamabe A, Irisawa A, Shibukawa G et al. Clinical effects of eosinophilic esophagitis observed using endoscopic ultrasound. Clin J Gastroenterol 2014;7:305–309.PubMed
120.
Kagalwalla AF, Wechsler JB, Amsden K et al. Efficacy of a 4-food elimination diet for children with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2017;15:1698-1707.e1697.PubMedPubMedCentral
121.
Dellon ES, Cotton CC, Gebhart JH et al. Accuracy of the eosinophilic esophagitis endoscopic reference score in diagnosis and determining response to treatment. Clin Gastroenterol Hepatol 2016;14:31–39.PubMed
122.
Kia L, Nelson M, Zalewski A et al. Oral delivery of fluticasone powder improves esophageal eosinophilic inflammation and symptoms in adults with eosinophilic esophagitis. Dis Esophagus 2018;31.
123.
Konikoff MR, Noel RJ, Blanchard C et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006;131:1381–1391.PubMed
124.
Lieberman JA, Morotti RA, Konstantinou GN, Yershov O, Chehade M. Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: a historical cohort. Allergy 2012;67:1299–1307.PubMed
125.
Hirano I, Collins MH, Assouline-Dayan Y et al. RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis. Gastroenterology 2019;156:592-603.e510.PubMed
126.
Hirano I, Dellon ES, Hamilton JD et al. Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis. Gastroenterology 2020;158:111-122.e110.PubMed
127.
Assa’ad AH, Gupta SK, Collins MH et al. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology 2011;141:1593–1604.PubMed
128.
Xiong XF, Zhu M, Wu HX, Fan LL, Cheng DY. Efficacy and safety of dupilumab for the treatment of uncontrolled asthma: a meta-analysis of randomized clinical trials. Respir Res 2019;20:108.PubMedPubMedCentral
129.
Nhu QM, Hsieh L, Dohil L et al. Antifibrotic effects of the thiazolidinediones in eosinophilic esophagitis pathologic remodeling: a preclinical evaluation. Clin Transl Gastroenterol 2020;11:e00164.PubMedPubMedCentral
130.
Dellon ES, Gibbs WB, Rubinas TC et al. Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. Gastrointest Endosc 2010;71:706–712.PubMed
131.
132.
Hirano I. Dilation in eosinophilic esophagitis: to do or not to do? Gastrointest Endosc 2010;71:713–714.PubMed
133.
Greenberg S, Chang NC, Corder SR, Reed CC, Eluri S, Dellon ES. Dilation-predominant approach versus routine care in patients with difficult-to-treat eosinophilic esophagitis: a retrospective comparison. Endoscopy 2021.
134.
Dougherty M, Runge TM, Eluri S, Dellon ES. Esophageal dilation with either bougie or balloon technique as a treatment for eosinophilic esophagitis: a systematic review and meta-analysis. Gastrointest Endosc 2017;86:581-591.e583.PubMedPubMedCentral
135.
Menard-Katcher C, Furuta GT, Kramer RE. Dilation of pediatric eosinophilic esophagitis: adverse events and short-term outcomes. J Pediatr Gastroenterol Nutr 2017;64:701–706.PubMedPubMedCentral
136.
Moawad FJ, Molina-Infante J, Lucendo AJ, Cantrell SE, Tmanova L, Douglas KM. Systematic review with meta-analysis: endoscopic dilation is highly effective and safe in children and adults with eosinophilic esophagitis. Aliment Pharmacol Ther 2017;46:96–105.PubMed
137.
Moole H, Jacob K, Duvvuri A et al. Role of endoscopic esophageal dilation in managing eosinophilic esophagitis: a systematic review and meta-analysis. Medicine 2017;96:e5877.PubMedPubMedCentral
138.
Al-Hussaini A. Savary dilation is safe and effective treatment for esophageal narrowing related to pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2016;63:474–480.PubMedPubMedCentral
139.
Runge TM, Eluri S, Cotton CC et al. Outcomes of esophageal dilation in eosinophilic esophagitis: safety, efficacy, and persistence of the fibrostenotic phenotype. Am J Gastroenterol 2016;111:206–213.PubMedPubMedCentral
140.
Lipka S, Keshishian J, Boyce HW, Estores D, Richter JE. The natural history of steroid-naïve eosinophilic esophagitis in adults treated with endoscopic dilation and proton pump inhibitor therapy over a mean duration of nearly 14 years. Gastrointest Endosc 2014;80:592–598.PubMed
141.
Ukleja A, Shiroky J, Agarwal A, Allende D. Esophageal dilations in eosinophilic esophagitis: a single center experience. World J Gastroenterol 2014;20:9549–9555.PubMedPubMedCentral
142.
Moawad FJ, Cheatham JG, DeZee KJ. Meta-analysis: the safety and efficacy of dilation in eosinophilic esophagitis. Aliment Pharmacol Ther 2013;38:713–720.PubMed
143.
Jung KW, Gundersen N, Kopacova J et al. Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis. Gastrointest Endosc 2011;73:15–21.PubMed
144.
145.
Karapiperis D, Malmstrom C, Vrakas S et al. Eosinophilic esophagitis and gastresophageal reflux disease: an overlapping of clinical, endoscopic and manometric features. Cureus 2021;13:e15774.PubMedPubMedCentral
146.
Amieva-Balmori M, Cano-Contreras AD, Remes-Troche JM. “Jackhammer esophagus” and eosinophilic esophagitis. Rev Gastroenterol Mex 2015;80:217–219.PubMed
147.
Tanaka S, Toyonaga T, Kawara F et al. A case of Jackhammer esophagus caused by eosinophilic esophagitis in which per-oral endoscopic myotomy resulted in symptom improvement. Clin J Gastroenterol 2018;11:377–381.PubMed
Metadata
Title
Pathophysiology of Dysphagia in Eosinophilic Esophagitis: Causes, Consequences, and Management
Authors
Edward Young
Hamish Philpott
Publication date
01-04-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-022-07419-6

Other articles of this Issue 4/2022

Digestive Diseases and Sciences 4/2022 Go to the issue

Original Article

History of Diverticulitis and Risk of Incident Cardiovascular Disease in Men: A Cohort Study

Original Article

Baseline Histological Findings Do Not Predict the Risk of Subsequent Extension in Patients with Limited Ulcerative Colitis

Original Article

Cost-Effectiveness of Empirical Bismuth-Based Quadruple Therapy and Tailored Therapy After Clarithromycin Resistance Tests for Helicobacter pylori Eradication

Original Article

Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease

Editorial

Introducing Dr. Smith, Dr. Wang, and Emily

Original Article

Thiopurine Monotherapy Is Effective in Maintenance of Mild-Moderate Inflammatory Bowel Disease

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits